Available to SourceHuman Prescription DrugOncology & Specialty

Vitrakvi (Larotrectinib)

20 mg/mL · Solution Concentrate

By Bayer HealthCare Pharmaceuticals Inc.

Larotrectinib · Solution, Concentrate · 20 mg/mL · Oropharyngeal

NDC: 50419-393
Route: Oropharyngeal
Therapeutic class: Kinase Inhibitor , Tropomyosin Receptor Kinases Inhibitors [MoA]
Marketing category: NDA

Package sizes

2 BOTTLE in 1 CARTON (50419-393-03) / 50 mL in 1 BOTTLE (50419-393-02)NDC 50419-393-03Available to Order

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Oncology & Specialty

See all →

Vitrakvi (Larotrectinib)

Package sizes

Additional information

Request this medication.

Related in Oncology & Specialty

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)